This technology is a PCR-based diagnostic method for rapid detection of SARS-CoV-2, influenza A and influenza B for a more accurate and sensitive diagnosis of a SARS-CoV-2 infection.
This technology is a programmable, multiplexed serodiagnostic method that detects SARS-CoV-2 specific epitopes and differentiates these from other human coronavirus epitopes, allowing for precise diagnosis of SARS-CoV-2 exposure.
